Among other subgroups of NB tumors, distal 1q-gain was seen in only 2/21 (9.5%) among cases with ATRX aberration and in 2/15 (13.3%) tumors with 11q-deletion but without genomic alteration of TERT or ATRX. This evidence concerns the gene TERT and neuroblastoma.